SecBot SecBot
SECBOTREPLAY Home › Report › SNY

SNY · Sanofi won dismissal with prejudice of a product liability lawsuit over…

Sanofi · COURT-RULING filed Aug 16, 2026 at 20:00 ET

At the news

BULLISHIMPACT 4/10

COURT-RULING filed Aug 16, 2026 at 20:00 ET

Sanofi won dismissal with prejudice of a product liability lawsuit over its drug Rezurock (belumosudil). The court granted the motion to dismiss under Rule 12(b)(6), finding the claims were time-barred and preempted by federal law, and denied leave to amend. This removes a small litigation overhang with no material financial exposure for a $109.7B company, but the stock impact is negligible given the case's trivial size and the company's market cap.

  • Sanofi (SNY) won dismissal with prejudice of a product liability lawsuit over Rezurock (belumosudil) in the Eastern District of California.
  • The court found the claims were time-barred under California's two-year statute of limitations and preempted by the FDCA.
  • Plaintiff's complaint was dismissed without leave to amend, and the case is closed.
  • No damages were awarded; the opinion does not state any amount sought by the plaintiff.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access